Skip to content

Clinical trials

Splenomegaly trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Splenomegaly Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20081
20121
20131
20141
20152
20161
20174
20192
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Terminated4
Active, not recruiting2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
CTI BioPharma2
National Institute of Allergy and Infectious Diseases (NIAID)2
AbbVie1
Brigham and Women's Hospital1
City of Hope Medical Center1
John Mascarenhas1
Koneti Rao1
National Human Genome Research Institute (NHGRI)1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Splenomegaly20
Primary Myelofibrosis9
Anemia7
Bone Marrow Diseases4
Hematologic Diseases4
Lymphadenopathy4
Thrombocytopenia4
Autoimmune Lymphoproliferative Syndrome3
Fever3
Hepatomegaly3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.